Femme Homme
- | Pays :
- Serbia
- Greece
- Bulgaria
- Les 7 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized, parallel-arm, open-label, multi-centre, Phase II study to determine the efficacy and safety of lapatinib in combination with vinorelbine or capecitabine in women with ErbB2 overexpressing metastatic breast cancer (MBC) who have received no more than one chemotherapeutic regimen in the metastatic setting.
Critère d'inclusion
- Cancer